Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$766
+$173 QoQ
Shares Held
9
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#457
of 477 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prestige Wealth Management Group LLC holds $465,680 across 25 Biotechnology names. CYTK ranks #21 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
556 | $276,181 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
201 | $60,507 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63 | $39,282 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
7,750 | $16,972 | |
| 5 | INCY |
Incyte Corp
|
132 | $14,963 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
124 | $10,107 | |
| 7 | MRNA |
Moderna, Inc.
|
137 | $9,594 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
200 | $6,544 |
All Filings in CYTK
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $766 | 9 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $593 | 9 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $571 | 9 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $494 | 9 | Shares | Other | 2026-02-20 | |
| 2025-06-30 | $297 | 9 | Shares | Other | 2026-02-20 | |
| 2025-03-31 | $361 | 9 | Shares | Other | 2026-02-20 | |
| 2024-12-31 | $423 | 9 | Shares | Other | 2026-02-20 | |
| 2024-09-30 | $475 | 9 | Shares | Other | 2026-02-20 | |
| 2024-06-30 | $487 | 9 | Shares | Other | 2026-02-20 | |
| 2024-03-31 | $630 | 9 | Shares | Other | 2024-04-26 | |
| 2023-12-31 | $751 | 9 | Shares | Other | 2024-04-26 | |
| 2023-09-30 | $265 | 9 | Shares | Other | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||